Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 127,933 | 78,360 | 60,228 | 24,618 | -73,876 |
| Depreciation Amortization | 246,003 | 193,061 | 133,958 | 66,970 | 265,288 |
| Accounts receivable | -120,579 | -111,058 | -33,723 | 21,146 | -162,155 |
| Other Working Capital | -204,516 | -192,226 | -141,488 | -106,380 | -4,068 |
| Other Operating Activity | 291,151 | 241,540 | 72,252 | 1,054 | 269,910 |
| Operating Cash Flow | $339,992 | $209,677 | $91,227 | $7,408 | $295,099 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -96,749 | -54,295 | -39,245 | -13,598 | -60,340 |
| Purchase Sale Intangibles | -15,514 | -12,514 | -5,100 | -4,200 | -14,650 |
| Other Investing Activity | -15,514 | -12,514 | -5,100 | -4,200 | -2,656 |
| Investing Cash Flow | $-112,263 | $-66,809 | $-44,345 | $-17,798 | $-62,996 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 218,000 | 218,000 | N/A | N/A |
| Debt Issued | 2,912,750 | 2,694,750 | N/A | 218,000 | 48,000 |
| Debt Repayment | -2,811,508 | -2,805,384 | -251,076 | -235,528 | -188,918 |
| Common Stock Issued | 1,960 | 1,407 | 754 | 69 | 1,154 |
| Other Financing Activity | -134,732 | -130,183 | -48,531 | -21,707 | -72,027 |
| Financing Cash Flow | $-31,530 | $-21,410 | $-80,853 | $-39,166 | $-211,791 |
| Exchange Rate Effect | -1,680 | -1,471 | -777 | -470 | -999 |
| Beginning Cash Position | 118,420 | 118,420 | 118,420 | 118,420 | 99,107 |
| End Cash Position | 312,939 | 238,407 | 83,672 | 68,394 | 118,420 |
| Net Cash Flow | $194,519 | $119,987 | $-34,748 | $-50,026 | $19,313 |
| Free Cash Flow | |||||
| Operating Cash Flow | 339,992 | 209,677 | 91,227 | 7,408 | 295,099 |
| Capital Expenditure | -98,843 | -55,674 | -40,624 | -14,122 | -60,340 |
| Free Cash Flow | 241,149 | 154,003 | 50,603 | -6,714 | 234,759 |